PTC Therapeutics
PTCT
#3036
Rank
ยฃ4.02 B
Marketcap
ยฃ48.14
Share price
0.21%
Change (1 day)
-16.14%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2026 (TTM): -ยฃ0.97

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.99. In 2025 the company made an earnings per share (EPS) of ยฃ6.67 an increase over its 2024 EPS that were of -ยฃ3.59.

EPS history for PTC Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.97-114.52%
2025ยฃ6.67-285.84%
2024-ยฃ3.59
2022-ยฃ5.914.85%
2021-ยฃ5.63
2019-ยฃ3.3966.17%
2018-ยฃ2.0429.33%
2017-ยฃ1.58-50.12%
2016-ยฃ3.16-17.59%
2015-ยฃ3.8457.63%
2014-ยฃ2.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
ยฃ3.98-500.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
ยฃ11.88-1,296.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ1.19 19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ1.99 100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-ยฃ0.80-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-ยฃ3.17 219.08%๐Ÿ‡บ๐Ÿ‡ธ USA